Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis

Journal of Surgical Research

Volumn 70, Issue 2, 1997, Pages 161-165

  Klaerner, Hans G ^a   Uknis, Marc E ^a   Acton, Robert D ^a   Dahlberg, Peter S ^a   Carlone Jambor, Cassandra ^a   Dunn, David L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; MUCIN;

ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; ESCHERICHIA COLI; MALE; MICROBIAL GROWTH; MORTALITY; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL;

EID: 0031194817     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5110     Document Type: Article

References (29)

1. Dyess D. L., Garrison R. N., Fry D. E. Candidal sepsis: Implications of polymicrobial blood-borne infection. Arch. Surg. 120:1985;345.
2. Verghese A., Prabhu K., Diamond R. D. Synchronous bacterial and fungal septicemia: A marker for the critically ill surgical patient. Am. Surg. 54:1988;276.
3. Klastersky J., Glauser M. P., Schimpff S. C. Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients. Antimicrob. Agents Chemother. 29:1986;263.
4. Ispahani P., Pearson N. J., Greenwood D. An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. Q. J. Med. 63:1987;427.
5. Wey S. B., Mori M., Pfaller M. A. Hospital-acquired candidemia: The attributable mortality and excess length of stay. Arch. Intern. Med. 148:1988;2642.
6. Solomkin J. S., Flohr A. B., Quie P. G. The role ofCandida. Surgery. 88:1980;524.
7. Solomkin J. S., Flohr A. B., Simmons R. L. Indications for therapy for fungemia in postoperative patients. Arch. Surg. 117:1982;1272.
8. Rault R. Candida. Am. J. Kidney Dis. 2:1983;544.
9. Andersen K. E. H., Olsen H. Candida. Scand. J. Infect. Dis. 10:1978;91.
10. Horn R., Wong B., Kiehn T. E. Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy. Rev. Infect. Dis. 7:1985;646.
11. Kwon-Chung K. J., Bennett J. E. Medical Mycology. 1992;Lea & Febiger, Philadelphia/London. p. 298-299.
12. Gale D., Sandova D. Response of mice to the inoculation of bothCandida albicansEscherichia coli. J. Bacteriol. 73:1956;616.
13. Yamabayashi H. A zymosanlike substance extracted fromCandida albicans. Med. J. Osaka Univ. 9:1958;11.
14. Burd R. S., Raymond C. S., Dunn D. L. Endotoxin promotes synergistic lethality during concurrentEscherichia coliCandida albicans. J. Surg. Res. 52:1992;537.
15. Sawyer R. G., Adams R. B., May A. K. Development ofCandida albicansC. albicansEscherichia coliBacteroides fragilis. J. Med. Vet. Mycol. 33:1995;49.
16. Dunn D. L., Barke R. A., Lee J. T. Jr. Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. VII. Hemoglobin does not inhibit clearance ofEscherichia coli. Surgery. 94:1982;487.
17. Hau T., Hoffman R., Simmons R. L. Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. I.In vivo. Surgery. 83:1977;223.
18. Pruett T. L., Rotstein O. D., Fiegel V. D. Mechanism of the adjuvant effect of hemoglobin in experimental peritonitis. VIII. A leukotoxin is produced byEscherichia coli. Surgery. 96:1984;375.
19. Landy M., Batson H. C. On the identity of the "virulence enhancement" factor in gastric mucin. J. Immunol. 62:1949;477.
20. Sawyer M. D., Dunn D. L. Antimicrobial therapy of intra-abdominal sepsis. Infect. Dis. Clin. North Am. 6:1992;545.
21. Rotstein O. D., Pruett T. L., Simmons R. L. Mechanisms of microbial synergy in polymicrobial surgical infections. Rev. Infect. Dis. 7:1985;151.
22. Gorbach S. L., Nahas L., Lerner P. I. Studies of intestinal microflora. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology. 53:1967;845.
23. Gorbach S. L., Plaut A. G., Nahas L. Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and fecal flora. Gastroenterology. 53:1967;856.
24. Giannella R. A., Broitman S. A., Zamcheck N. Gastric acid barrier to ingested microorganisms in man: Studiesin vivoin vitro. Gut. 13:1972;251.
25. Bayer A. S., Blumenkrantz M. J., Montgomerie J. Z. Candida. Am. J. Med. 61:1976;832.
26. Neely A. N., Law E. J., Holder I. A. Increased susceptibility to lethalCandidaPseudomonas aeruginosa. Infect. Immun. 52:1986;200.
27. Carlson E., Johnson G. Protection byCandida albicansStaphylococcus aureus. Infect. Immun. 50:1985;655.
28. Carlson E. Enhancement byCandida albicansStaphylococcus aureus, Serratia marcescens,Streptococcus faecalis. Infect. Immun. 39:1983;193.
29. Dunn D. L., Rotstein O. D., Simmons R. L. Fibrin in peritonitis. IV. Synergistic intraperitoneal infection due toEscherichia coliBacteroides fragilis. Arch. Surg. 119:1984;139.